Fig. 6: Comparative analysis of VCL-ICAM1 exudation-adhesion pathway.
From: VCL/ICAM-1 pathway is associated with lung inflammatory damage in SARS-CoV-2 Omicron infection
a–c Correlation analysis between VCL and key indicators in Omi-Asymptomatic, Omi-Symptomatic, and ancestral groups. d–f Scatter plots illustrating the correlation of VCL with CRP, CT scores, and other clinical markers in Omi-Asymptomatic, Omi-Symptomatic, and ancestral groups. g Overall differences in N-glycosylation across healthy controls, Omi-Asymptomatic, Omi-Symptomatic, and ancestral groups. h N-glycosylation model diagram of VCL. Created in BioRender. Xue, M. (2025) https://BioRender.com/m14t653. i-j Comparison of N-glycosylation levels of VCL and ICAM-1 across different patient groups. Data are presented as mean values ± SEM. n (healthy control) = 20. n (Omi-Asymptomatic) = 20. n (Omi-Symptomatic) = 20. n (ancestral) = 20. Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test for multiple comparisons. *P < 0.05. **P < 0.01.***P < 0.001.
